AMPIO PHARMACEUTICALS

ampio-pharmaceuticals-logo

Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs selected from its extensive portfolio with the potential to be safe and effective for improving patient care. The companyโ€™s product pipeline includes new uses for approved drugs and new molecular entities (โ€œNMEsโ€) for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. Central to the companyโ€™s successful clinical development programs ar... e its strong relationships with clinicians, academic medical centers, regional hospitals and specialized product and service providers. A phase II clinical development program is underway in addition to sponsored basic, translational and clinical research projects aimed at specific disease mechanisms. The company has built a robust portfolio of issued patents and pending patent applications on its products.

#SimilarOrganizations #People #Website #More

AMPIO PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2011-01-01

Address:
Greenwood Village, Colorado, United States

Country:
United States

Website Url:
http://www.ampiopharma.com

Total Employee:
11+

Status:
Active

Contact:
720-437-6500

Email Addresses:
[email protected]

Total Funding:
75.89 M USD

Technology used in webpage:
Google Maps IPv6 Microsoft Cogent Communications


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

glycomimetics-logo

GlycoMimetics

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

Current Employees Featured

michael-macaluso_image

Michael Macaluso
Michael Macaluso Founder & CEO @ Ampio Pharmaceuticals
Founder & CEO

not_available_image

David Bar
David Bar CSO @ Ampio Pharmaceuticals
CSO

not_available_image

Mark McGregor
Mark McGregor CFO @ Ampio Pharmaceuticals
CFO

not_available_image

Daniel Stokely
Daniel Stokely Executive Vice President / Chief Financial Officer @ Ampio Pharmaceuticals
Executive Vice President / Chief Financial Officer
2019-07-01

josh-disbrow_image

Josh Disbrow
Josh Disbrow COO @ Ampio Pharmaceuticals
COO

not_available_image

David R. Stevens
David R. Stevens Director @ Ampio Pharmaceuticals
Director

not_available_image

Vaughan Clift
Vaughan Clift Chief Regulatory Affairs Officer @ Ampio Pharmaceuticals
Chief Regulatory Affairs Officer

philip-coelho_image

Philip Coelho
Philip Coelho Director @ Ampio Pharmaceuticals
Director

michael-a-martino_image

Michael A. Martino
Michael A. Martino Chairman & CEO @ Ampio Pharmaceuticals
Chairman & CEO
2021-11-01

Founder


michael-macaluso_image

Michael Macaluso

Stock Details


Company's stock symbol is NYSEMKT:AMPE

Official Site Inspections

http://www.ampiopharma.com Semrush global rank: 13.11 M Semrush visits lastest month: 78

  • Host name: 3.246.109.208.host.secureserver.net
  • IP address: 208.109.246.3
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Ampio Pharmaceuticals"

Ampio Pharmaceuticals - Ampio Pharmaceuticals

Stipulation and Agreement of Settlement, dated January 8, 2025. Notice of Proposed Derivative Settlement, dated January 21, 2025. Dear Ampio Stockholders:See details»

Ampio Pharmaceuticals - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 720-437-6500 Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs selected from its extensive portfolio with the โ€ฆSee details»

Ampio Pharmaceuticals (AMPE) Profile - The Globe and Mail

Mar 25, 2024 See the company profile for Ampio Pharmaceuticals (AMPE) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»

Ampio Pharmaceuticals, Inc. | LinkedIn

Ampio Pharmaceuticals, Inc. | 603 followers on LinkedIn. Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at ...See details»

Ampio Pharmaceuticals, Inc. (AMPE)

See the company profile for Ampio Pharmaceuticals, Inc. (AMPE) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Ampio Pharmaceuticals, Inc. - Dun & Bradstreet

Company Description: With hopes one day of taking in revenues somewhere between ample and copious, Ampio Pharmaceuticals is a development-stage company that focuses on โ€ฆSee details»

Ampio Provides Litigation Update Reports Settlement in Principle โ€ฆ

ENGLEWOOD, Colo., January 11, 2024 โ€“ Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the โ€œCompanyโ€ or โ€œAmpioโ€), a pre-revenue stage biopharmaceutical company focused on โ€ฆSee details»

Ampio Pharmaceuticals Company Description - Stock Analysis

Company profile for Ampio Pharmaceuticals, Inc. (AMPE) with a description, list of executives, contact details and other key facts.See details»

Ampio Letter to Stockholders - Ampio ... - Ampio Pharmaceuticals

ENGLEWOOD, Colo., August 3, 2022 โ€” Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi and Chief โ€ฆSee details»

Ampio Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...

ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that, as previously disclosed โ€ฆSee details»

Ampio Pharmaceuticals

Feb 25, 2025 Ampio Pharmaceuticals, Inc. was founded in 2004 with a mission to develop unique drugs derived from plants for the treatment of a broad range of diseases.See details»

AMPE - Ampio Pharmaceuticals, Inc. | Company Profile | OTC โ€ฆ

Ampiopharma.com +1 (720) 437-6500. [email protected]. Last Verified 12/2023. Business Description. Ampio Pharmaceuticals, Inc. is a pre-revenue stage biopharmaceutical company โ€ฆSee details»

Ampio Pharmaceuticals - Craft

Oct 29, 2024 Ampio Pharmaceuticals has 5 employees at their 1 location and $50 k in annual revenue in FY 2013. See insights on Ampio Pharmaceuticals including office locations, โ€ฆSee details»

AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

ENGLEWOOD, Colo., Jan. 17, 2023 โ€“ Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the โ€œCompanyโ€) today released the following letter to stockholders from its Chairman, Kevin โ€ฆSee details»

Ampio Pharmaceuticals - Overview, News & Similar companies

Who is Ampio Pharmaceuticals. Ampio Pharmaceuticals, Inc. is a biopharmaceutical company primarily focused on the advancement of immunology-based therapies to treat common infla โ€ฆSee details»

Ampio Pharmaceuticals Strengthens Management Team and โ€ฆ

ENGLEWOOD, Colo., Oct. 13, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory โ€ฆSee details»

Ampio Pharmaceuticals, Inc. (AMPE) - Yahoo Finance Canada

Find the latest Ampio Pharmaceuticals, Inc. (AMPE) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO โ€ฆ

Ascendia, a specialty contract development and manufacturing organization (CDMO) leader, will provide Ampio with a range of services including formulation development, process โ€ฆSee details»

Amplio Pharma Company Profile 2025: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for Amplio Pharma. Use the PitchBook Platform to explore the full profile.See details»

Ampio Pharmaceuticals Issues Letter to Stockholders

Proposal to Authorize Reverse Stock Split has Been Approved ENGLEWOOD, Colo., October 14, 2022 โ€” Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), today released the โ€ฆSee details»

linkstock.net © 2022. All rights reserved